{"id":"W6958715052","doi":"10.6084/m9.figshare.c.6815738","title":"Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant","year":2023,"lang":"en","type":"other","venue":"Figshare","topic":"Legal and Regulatory Analysis","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fulvestrant; Placebo; Hazard ratio; Cancer; Letrozole; Proportional hazards model; Breast cancer; Overall survival; Discontinuation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002246686,0.0003977447,0.0006422512,0.0001135643,0.000334047,0.0001525275,0.00069859,0.0004244831,0.2852671],"category_scores_gemma":[0.0001633408,0.0002599067,0.0001112643,0.0007737725,0.00007829737,0.0001891677,0.000109394,0.0004897639,0.0004498787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005862031,"about_ca_system_score_gemma":0.0007110361,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.04156318,"about_ca_topic_score_gemma":0.4033815,"domain_scores_codex":[0.9972759,0.0003087401,0.0003368358,0.0006291546,0.0007820037,0.0006673267],"domain_scores_gemma":[0.9986655,0.0003251079,0.0003641804,0.0003748182,0.00008288971,0.0001875023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01080986,0.0002620346,0.0006945518,0.0001356465,0.001634775,0.0003059348,0.01156154,0.002274372,0.000008805031,0.00005946592,0.965609,0.006644026],"study_design_scores_gemma":[0.01105682,0.0001300751,0.01264021,0.00343008,0.00009707093,8.265511e-7,0.001024981,0.00004760739,0.000001311038,0.00007959472,0.9707386,0.0007528074],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"other","genre_scores_codex":[0.02766348,0.001940314,3.362861e-7,0.005327361,0.001499629,0.00300338,0.8862634,0.001354578,0.07294754],"genre_scores_gemma":[0.1180401,0.001005863,0.00003567317,0.0007478999,0.01152291,0.002645696,0.08975937,0.001783688,0.7744588],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.796504,"threshold_uncertainty_score":0.9999853,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02568492124329212,"score_gpt":0.2820047223580319,"score_spread":0.2563198011147398,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}